Major
Metformin × Prednisolone
Biguanides. Oral antihyperglycemic agents×Glucocorticoids
Mechanism
Prednisolone (a systemic glucocorticoid) suppresses muscle glucose uptake and stimulates hepatic gluconeogenesis – steroid-induced diabetes develops or existing type 2 diabetes decompensates. Metformin offsets part of the effect but not all.
Symptoms
Hyperglycaemia: thirst, polyuria, fatigue, rising fasting glucose and HbA1c. With high prednisolone doses: decompensation risk with ketoacidosis in type 1 diabetes.
Management
Monitor glucose 4 times daily during the first week of combination, then by self-monitoring. Increase metformin to maximum (2000–2500 mg/day) as needed. If decompensation occurs, add an α-glucosidase inhibitor, a GLP-1 receptor agonist, or temporary insulin.
Sources
- ADA: Standards of Care in Diabetes – 2024 (Section 3, Prevention of Diabetes) (2024)– American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes–2024. Diabetes Care 2024;47(Suppl 1):S43-S51.
- FDA: Glucophage (metformin hydrochloride) prescribing information (2017)